Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Key: Intezyne Technologies, Inc. (1) Acquired (1)
irinotecan (Camptosar) (1 trial)
nkp-1339 (1 trial)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (2 total)